Researchers at the University of Alabama at Birmingham have discovered a way to prevent kidney failure from occurring in people with multiple...
News
JOIN THE MARCH
For those who are able to, including family and friends, we urge you to join us on Tuesday 7 May in Wellington to march for the RIGHT TO LIVE. We'll...
Newsletter: April 2019
Greetings to everyone as the days draw in. We are intending to generate some heat with various planned activities over the next month. There has...
Patient Seminar with Prof. Nikhil C. Munshi: Minimal residual disease in Myeloma sessions
https://vimeo.com/330610777 https://vimeo.com/330611169
Imaging in multiple myeloma: How? When?
Bone disease is the most frequent feature of multiple myeloma (MM) and represents a marker of end-organ damage; it is used to establish the...
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised,...
Going the distance: Are we losing patients along the multiple myeloma treatment pathway?
Despite data suggesting that individuals with multiple myeloma can benefit from receiving several lines of therapy, and guidelines recommending...
Single-cell Profiling in Multiple Myeloma May Improve Diagnosis, Treatment, Study Suggests
Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic,...
Lenalidomide Maintenance Therapy for Multiple Myeloma
Orally administered lenalidomide, a second-generation antimyeloma thalidomide analog, is a workhorse in contemporary management of multiple myeloma:...
Myeloma Study Makes the Case for a New Standard for Predicting Long-Term Outcome
As new treatments for multiple myeloma have extended patient survival—from an average of three years to more than 10 in some cases—physicians and...
Increased Risk of Myeloma in African Americans Driven By Higher Rates of 3 Disease Subtypes
Multiple myeloma (MM)Â and monoclonal gammopathy of undetermined significance (MGUS), a precursor to MM, are 2 to 3 times more common in African...
THE ELUSIVE C-WORD: CURE?
Until now, myeloma patients whose cancer was resistant to commonly used treatment methods and drugs had nowhere to turn. But a Phase 2 CAR T-cell...